Calian Group Ltd. (TSE:CGY – Get Free Report) has received an average recommendation of “Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is C$69.67.
CGY has been the subject of a number of research reports. CIBC reduced their target price on shares of Calian Group from C$63.00 to C$62.00 in a report on Friday, February 14th. Acumen Capital reduced their price objective on Calian Group from C$75.00 to C$70.00 in a research note on Wednesday, November 27th. Finally, Ventum Financial reduced their price objective on Calian Group from C$70.00 to C$68.00 in a research note on Wednesday, November 27th.
Read Our Latest Research Report on CGY
Insider Transactions at Calian Group
Calian Group Price Performance
TSE CGY opened at C$43.26 on Wednesday. Calian Group has a 52 week low of C$39.41 and a 52 week high of C$60.18. The firm has a market capitalization of C$513.54 million, a P/E ratio of 46.32, a PEG ratio of 2.50 and a beta of 0.88. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company has a 50-day moving average price of C$46.11 and a 200-day moving average price of C$47.28.
Calian Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 12th. Stockholders of record on Wednesday, March 12th were paid a $0.28 dividend. The ex-dividend date was Wednesday, February 26th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 2.59%. Calian Group’s dividend payout ratio (DPR) is presently 119.93%.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Featured Stories
- Five stocks we like better than Calian Group
- How to Invest in the FAANG Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Must-Own Stocks to Build Wealth This Decade
- Most Volatile Stocks, What Investors Need to Know
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.